Visitors at this page also visited
H. influenzae vaccine
The Haemophilus influenzae type B vaccine, often called Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b (Hib) infection. In countries that include it as a routine vaccine, rates of severe Hib infections have decreased more than 90%. It has therefore resulted in a decrease in the rate of meningitis, pneumonia, and epiglottitis. It is given by injection into a muscle.Severe side effects are uncommon. About 20 to 25% of people develop pain at the site of injection while about 2% develop a fever.There is no clear association with severe allergic reactions. The Hib vaccine is available by itself, in combination with the diphtheria/tetanus/pertussis vaccine, and in combination with the hepatitis B vaccine, among others.All Hib vaccines that are currently used are conjugate vaccine. An initial Hib vaccine was developed in 1977 which was replaced by a more effective formulation in the 1990s.As of 2013, 184 countries include it in their routine vaccinations. (source)
Similar pages on this site
Good to know
Are we over-medicalized?
Ivan Oransky, the executive editor of Reuters Health
Are you happy with your blood test results?
Full of information that could make patients healthier, and evoke their engagement
When Evidence Says No, but Doctors Say Yes - An Epidemic of Unnecessary Treatment
David Epstein and Propublica, The Atlantic